ArticleBlood2023

Characterization of the bone marrow niche in patients with chronic myeloid leukemia identifies CXCL14 as a new therapeutic option.

Monika Dolinska et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.